| Product NDC: | 0591-0582 | 
| Proprietary Name: | Propafenone HCl | 
| Non Proprietary Name: | Propafenone hydrochloride | 
| Active Ingredient(s): | 150 mg/1 & nbsp; Propafenone hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0591-0582 | 
| Labeler Name: | Watson Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075203 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20001024 | 
| Package NDC: | 0591-0582-05 | 
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0582-05) | 
| NDC Code | 0591-0582-05 | 
| Proprietary Name | Propafenone HCl | 
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0582-05) | 
| Product NDC | 0591-0582 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Propafenone hydrochloride | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20001024 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Watson Laboratories, Inc. | 
| Substance Name | PROPAFENONE HYDROCHLORIDE | 
| Strength Number | 150 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Antiarrhythmic [EPC] |